Recent studies have revealed that GABA signaling is involved not only in classical immune evasion but also in mediating immunotherapy resistance by regulating immune checkpoint molecule expression, promoting the accumulation of immunosuppressive cells (such as regulatory T cells and tumor-associated macrophages), and suppressing the activity of effector CD8+ T cells (11, 40, 65). This evidence concerns the gene CD8A and neoplasm.